Sotera Health, of Broadview Heights, announced today that it has acquired New Jersey-based Gibraltar Laboratories.
Terms of the deal were not disclosed.
Sotera Health is owned by private equity firms Warburg Pincus and GTCR. With 2,600 employees globally, Sotera provides services to the medical device, pharmaceutical, tissue and food industries.
“Gibraltar Laboratories is a well-respected laboratory known for its strong customer relationships with U.S.-based pharmaceutical manufacturers,” Michael B. Petras Jr., CEO of Sotera Health said in a statement.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“In addition to its testing expertise, Gibraltar’s facilities are located in the Northeast pharmaceutical corridor, home to many of the top pharmaceutical manufacturers in the United States. This acquisition will expand our presence in this important region and further strengthen our testing capabilities for the pharmaceutical industry.”
Headquartered in Fairfield, New Jersey, Gibraltar Laboratories provides microbiology and analytical chemistry testing for pharmaceutical and medical device manufacturers.
Date: August 08, 2018
